Methyl-d-erythritol phosphate pathway genes
CA 2418436 C · Owner: Campos, Narciso · Inventors: Rodriguez-Concepcion, Manuel; Seemann, Myriam; Campos, Narciso
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides and includes nucleic acids proteins and , antibodies associated with novel genes in the MEP pathway. The invention further encompasses methods utilizing such molecules, for example in gene isolation gene analysis , and the production of transgenic plants. The present invention also includes transgenic plants modified to express proteins associated with the MEP pathway.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 6, 2001 and granted July 11, 2017. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 6, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 6, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.